Yanchen Xie

No.95 Yongan Road
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Rs1800629 polymorphism in TNF-alpha is associated with the susceptibility and initial short-term glucocorticoids efficacy in myasthenia gravis patients.

Rs1800629 polymorphism in TNF-alpha is associated with the susceptibility and initial short-term glucocorticoids efficacy in myasthenia gravis patients.

Journal: Journal of neuroimmunology

Published: October 15, 2023

Criteria for Treatment Response in Myasthenia Gravis: Comparison Between Absolute Change and Improvement Percentage in Severity Scores.

Criteria for Treatment Response in Myasthenia Gravis: Comparison Between Absolute Change and Improvement Percentage in Severity Scores.

Journal: Frontiers in neurology

Published: February 20, 2022

Complement C3 polymorphism is associated with the susceptibility of myasthenia gravis in Chinese adult patients.

Complement C3 polymorphism is associated with the susceptibility of myasthenia gravis in Chinese adult patients.

Journal: Journal of neuroimmunology

Published: July 20, 2020

The Electrophysiological Features in X-Linked Charcot-Marie-Tooth Disease With Transient Central Nervous System Deficits.

The Electrophysiological Features in X-Linked Charcot-Marie-Tooth Disease With Transient Central Nervous System Deficits.

Journal: Frontiers in neurology

Published: April 03, 2018

IL-4Rα Polymorphism Is Associated With Myasthenia Gravis in Chinese Han Population.

IL-4Rα Polymorphism Is Associated With Myasthenia Gravis in Chinese Han Population.

Journal: Frontiers in neurology

Published: February 16, 2018

TNFAIP3 gene rs7749323 polymorphism is associated with late onset myasthenia gravis.

TNFAIP3 gene rs7749323 polymorphism is associated with late onset myasthenia gravis.

Journal: Medicine

Published: May 18, 2017

Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity.

Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity.

Journal: Cytokine

Published: March 09, 2017

The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis.

The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis.

Journal: Frontiers in neurology

Published: February 13, 2017

Letter re: International consensus guidance for management of myasthenia gravis: Executive summary.

Letter re: International consensus guidance for management of myasthenia gravis: Executive summary.

Journal: Neurology

Published: February 01, 2017

Rs3761389 polymorphism in autoimmune regulator (AIRE) gene is associated with susceptibility of myasthenia gravis in Chinese patients.

Rs3761389 polymorphism in autoimmune regulator (AIRE) gene is associated with susceptibility of myasthenia gravis in Chinese patients.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: December 09, 2016

Precision medicine in myasthenia graves: begin from the data precision.

Precision medicine in myasthenia graves: begin from the data precision.

Journal: Annals of translational medicine

Published: April 30, 2016

Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.

Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.

Journal: Molecular neurobiology

Published: February 29, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026